320 related articles for article (PubMed ID: 24603322)
41. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
[TBL] [Abstract][Full Text] [Related]
42. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors.
Xiu L; Chang N; Yang L; Liu X; Yang L; Ge J; Li L
Am J Pathol; 2015 Feb; 185(2):387-98. PubMed ID: 25432063
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
Venkataraman K; Lee YM; Michaud J; Thangada S; Ai Y; Bonkovsky HL; Parikh NS; Habrukowich C; Hla T
Circ Res; 2008 Mar; 102(6):669-76. PubMed ID: 18258856
[TBL] [Abstract][Full Text] [Related]
44. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.
Takahashi C; Kurano M; Nishikawa M; Kano K; Dohi T; Miyauchi K; Daida H; Shimizu T; Aoki J; Yatomi Y
J Atheroscler Thromb; 2017 Sep; 24(9):954-969. PubMed ID: 28321011
[TBL] [Abstract][Full Text] [Related]
45. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
Serrano-Sanchez M; Tanfin Z; Leiber D
Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy.
Yamamoto Y; Olson DM; van Bennekom M; Brindley DN; Hemmings DG
Biol Reprod; 2010 Mar; 82(3):628-35. PubMed ID: 20007411
[TBL] [Abstract][Full Text] [Related]
48. Altered expression of sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 in mouse hippocampus after kainic acid treatment.
Lee DH; Jeon BT; Jeong EA; Kim JS; Cho YW; Kim HJ; Kang SS; Cho GJ; Choi WS; Roh GS
Biochem Biophys Res Commun; 2010 Mar; 393(3):476-80. PubMed ID: 20152803
[TBL] [Abstract][Full Text] [Related]
49. Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P
Uranbileg B; Nishikawa T; Ikeda H; Kurano M; Sato M; Saigusa D; Aoki J; Watanabe T; Yatomi Y
Clin Colorectal Cancer; 2018 Jun; 17(2):e171-e182. PubMed ID: 29223361
[TBL] [Abstract][Full Text] [Related]
50. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
Völzke A; Koch A; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
Biochim Biophys Acta; 2014 Jan; 1841(1):11-21. PubMed ID: 24064301
[TBL] [Abstract][Full Text] [Related]
51. Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis.
Kuchler L; Sha LK; Giegerich AK; Knape T; Angioni C; Ferreirós N; Schmidt MV; Weigert A; Brüne B; von Knethen A
Mol Immunol; 2017 Oct; 90():255-263. PubMed ID: 28846923
[TBL] [Abstract][Full Text] [Related]
52. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
Yafasova A; Mandrup CM; Egelund J; Nyberg M; Stallknecht B; Hellsten Y; Nielsen LB; Christoffersen C
J Appl Physiol (1985); 2019 Jan; 126(1):214-220. PubMed ID: 30433864
[TBL] [Abstract][Full Text] [Related]
53. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.
Mendoza A; Bréart B; Ramos-Perez WD; Pitt LA; Gobert M; Sunkara M; Lafaille JJ; Morris AJ; Schwab SR
Cell Rep; 2012 Nov; 2(5):1104-10. PubMed ID: 23103166
[TBL] [Abstract][Full Text] [Related]
54. Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.
Peltier L; Bendavid C; Cavey T; Island ML; Doyard M; Leroyer P; Allain C; De Tayrac M; Ropert M; Loréal O; Guggenbuhl P
Osteoporos Int; 2018 Aug; 29(8):1905-1915. PubMed ID: 29721575
[TBL] [Abstract][Full Text] [Related]
55. SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition.
Zhao T; Ding T; Sun Z; Shao X; Li S; Lu H; Yuan JH; Guo Z
FASEB J; 2024 Jan; 38(2):e23417. PubMed ID: 38226856
[TBL] [Abstract][Full Text] [Related]
56. Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells.
Pilorget A; Demeule M; Barakat S; Marvaldi J; Luis J; Béliveau R
J Neurochem; 2007 Mar; 100(5):1203-10. PubMed ID: 17316399
[TBL] [Abstract][Full Text] [Related]
57. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).
Barnawi J; Tran H; Jersmann H; Pitson S; Roscioli E; Hodge G; Meech R; Haberberger R; Hodge S
PLoS One; 2015; 10(10):e0122771. PubMed ID: 26485657
[TBL] [Abstract][Full Text] [Related]
58. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.
Aoki M; Aoki H; Ramanathan R; Hait NC; Takabe K
Mediators Inflamm; 2016; 2016():8606878. PubMed ID: 26966342
[TBL] [Abstract][Full Text] [Related]
59. A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression.
Wang S; Lin X; Wang LY; Ruan KF; Feng Y; Li XY
Int J Biol Macromol; 2012 Apr; 50(3):734-40. PubMed ID: 22197795
[TBL] [Abstract][Full Text] [Related]
60. Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.
Książek M; Charmas M; Klusiewicz A; Zabielski P; Długołęcka B; Chabowski A; Baranowski M
Scand J Med Sci Sports; 2018 Jan; 28(1):57-64. PubMed ID: 28493600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
